[ASAP] Development of a Gadolinium–Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00726 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
